Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Frontiers in Bioengineering and Biotechnology|February 14, 2022
Electrospun Silk Fibroin Scaffolds for Tissue Regeneration: Chemical, Structural, and Toxicological Implications of the Formic Acid-Silk Fibroin InteractionMarco Biagiotti, Giulia Alessandra Bassani, Anna Chiarini, et al.Biotechnology for Biofuels|August 31, 2017
Enhanced polyhydroxyalkanoate (PHA) production from the organic fraction of municipal solid waste by using mixed microbial cultureBianca Colombo, Francesca Favini, Barbara Scaglia, et al.Molecules (Basel, Switzerland)|October 27, 2022
Heparin-Superparamagnetic Iron Oxide Nanoparticles for Theranostic ApplicationsNicolò Massironi, Miriam Colombo, Cesare Cosentino, et al.Glycobiology|October 4, 2008
Glycosaminoglycan origin and structure revealed by multivariate analysis of NMR and CD spectraTimothy R Rudd, Mark A Skidmore, Scott E Guimond, et al.Frontiers in Chemistry|August 8, 2020
Design and Synthesis of Chitosan-Gelatin Hybrid Hydrogels for 3D Printable <i>in vitro</i> ModelsSofia Magli, Giulia Beatrice Rossi, Giulia Risi, et al.Carbohydrate Polymers|December 16, 2014
Heparin derivatives for the targeting of multiple activities in the inflammatory responseNoemi Veraldi, Ashley J Hughes, Timothy R Rudd, et al.Glycobiology|June 21, 2007
Influence of substitution pattern and cation binding on conformation and activity in heparin derivativesTimothy R Rudd, Scott E Guimond, Mark A Skidmore, et al.Biomedicines|September 28, 2021
Enisamium Inhibits SARS-CoV-2 RNA SynthesisStefano Elli, Denisa Bojkova, Marco Bechtel, et al.Biochemistry|April 30, 2009
Cations modulate polysaccharide structure to determine FGF-FGFR signaling: a comparison of signaling and inhibitory polysaccharide interactions with FGF-1 in solutionScott E Guimond, Timothy R Rudd, Mark A Skidmore, et al.Medrxiv : the Preprint Server for Health Sciences|January 20, 2021
Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trialOlha Holubovska, Denisa Bojkova, Stefano Elli, et al.Pageof 3